What is an albumin/creatinine ratio of 39.4 mg/g classified as?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification of Albumin/Creatinine Ratio of 39.4 mg/g

An albumin/creatinine ratio of 39.4 mg/g is classified as moderately increased albuminuria (formerly called microalbuminuria). 1, 2

Standard Classification Categories

The albumin-to-creatinine ratio is categorized into three distinct levels based on established guidelines 1, 2:

  • Normal: <30 mg/g creatinine 1, 2
  • Moderately increased albuminuria: 30-299 mg/g creatinine 1, 2
  • Severely increased albuminuria: ≥300 mg/g creatinine 1, 2

Your patient's value of 39.4 mg/g falls clearly within the moderately increased range. 1, 2

Confirmation Requirements Before Diagnosis

Do not diagnose albuminuria based on a single measurement. Due to high day-to-day variability (coefficient of variation ~49%), you must confirm this elevation with 2 additional specimens collected over a 3-6 month period before establishing a diagnosis of albuminuria. 1, 2, 3 Two of three specimens must be abnormal (≥30 mg/g) to confirm the diagnosis. 1

Factors That Can Cause False Elevations

Recheck the albumin/creatinine ratio after excluding these transient causes 1, 2:

  • Exercise within 24 hours
  • Active infection or fever
  • Congestive heart failure
  • Marked hyperglycemia
  • Marked hypertension
  • Menstruation (in females)

Clinical Significance and Next Steps

For Diabetic Patients

In youth with diabetes and hypertension, initiate an ACE inhibitor or angiotensin receptor blocker for moderately elevated urinary albumin-to-creatinine ratio (30-299 mg/g). 1 However, avoid these medications in individuals of childbearing age who are not using reliable contraception due to teratogenic effects. 1

For adults with diabetes, this level of albuminuria indicates early diabetic kidney disease and warrants 1, 2:

  • Monitoring ACR and eGFR at least annually (or every 6 months if eGFR <60 mL/min/1.73 m²) 2
  • Optimization of blood pressure control
  • Consideration of renin-angiotensin system blockade

Prognostic Implications

At any level of GFR, increased ACR is associated with higher risk for adverse cardiovascular and renal outcomes, with risk increasing progressively as ACR rises. 2 Even within the moderately increased range, your patient's value of 39.4 mg/g carries continuous risk—higher values within this category predict worse outcomes than lower values. 2

Practical Monitoring Considerations

The albumin/creatinine ratio demonstrates substantial within-individual variability. 3 When monitoring changes over time, a second UACR measurement may range from 0.26 to 3.78 times the initial value due to biological variation alone. 3 If you observe an increase from one measurement to another, obtaining 2 collections at each time point improves confidence that a true change has occurred. 3

For diagnostic purposes (confirming presence/absence of albuminuria), the ranges of diagnostic uncertainty are 2.0-4.0 mg/mmol after a single test, narrowing to 2.4-3.2 mg/mmol with the mean of 2 collections. 3 Multiple collections improve diagnostic accuracy but may not always be necessary for initial diagnosis. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Use of Creatinine in Albumin-to-Creatinine Ratio for Kidney Damage Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.